Osteoblastic bone flare on F18-FDG PET in Non-small Cell Lung Cancer (NSCLC) patients receiving bevacizumab in addition to standard chemotherapy

Journal of Thoracic Oncology

Volumn 4, Issue 3, 2009, Pages 429-431

  Krupitskaya, Yelena ^a   Eslamy, Hedieh K ^a   Nguyen, Dorothy D ^b   Kumar, Atul ^a   Wakelee, Heather A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Oncology/Hematology ^*  (United States)

Author keywords

Bevacizumab; Bone flare; Bone metastases; Chemotherapy; Discrepancy; Non small cell lung cancer; Osteoblastic bone reaction; Osteoblastic flare; Positron emission tomography

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; FLUORODEOXYGLUCOSE F 18; PACLITAXEL; PAMIDRONIC ACID; PLATINUM; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER GROWTH; CASE REPORT; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MALE; OSTEOBLAST; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME; ADENOCARCINOMA; BONE TUMOR; CANCER INVASION; CANCER STAGING; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; RISK ASSESSMENT; SCINTISCANNING; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; BONE NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OSTEOBLASTS; POSITRON-EMISSION TOMOGRAPHY; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 67049169381     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181989e12     Document Type: Article

References (7)

1. Cook GJ, Fogelman I. The role of positron emission tomography in the management of bone metastases. Cancer 2000;88(12 Suppl):2927-2933. (Pubitemid 30413175)
2. Ito S, Kato K, Ikeda M, et al. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer. J Nucl Med 2007;48:889-895. (Pubitemid 46909916)
3. Schneider JA, Divgi CR, Scott AM, et al. Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer. J Nucl Med1994;35:1748-1752. (Pubitemid 24346792)
4. Shimizu N, Masuda H, Yamanaka H, Oriuchi N, Inoue T, Endo K. Fluorodeoxyglucose positron emission tomography scan of prostate cancer bone metastases with flare reaction after endocrine therapy. J Urol 1999;161:608-609.
5. Cosolo W, Morstyn G, Arkles B, Zimet AS, Zalcberg JR. Flare responses in small cell carcinoma of the lung. Clin Nucl Med 1988;13: 13-16. (Pubitemid 18034409)
6. Coleman RE, Mashiter G, Whitaker KB, Moss DW, Rubens RD, Fogelman I. Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med 1988;29:1354-1359. (Pubitemid 18186714)
7. Lemieux J, Guimond J, Laberge F, St-Pierre C, Cormier Y. The bone scan flare phenomenon in non-small-cell lung cancer. Clin Nucl Med 2002;27: 486-489. (Pubitemid 35190369)